Spero Therapeutics Inc. (SPRO)
NASDAQ · Healthcare
Spero Therapeutics Inc. annual/quarterly total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Spero Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 9.9M, a 84.64% decrease year-over-year.
- Spero Therapeutics Inc. total liabilities for 2025 were 9.9M, a 84.64% decrease from 2024.
- Spero Therapeutics Inc. total liabilities for 2024 were 64.4M, a 14.67% decrease from 2023.
- Spero Therapeutics Inc. total liabilities for 2023 were 75.5M, a 54.49% increase from 2022.
- Spero Therapeutics Inc. total liabilities for 2022 were 48.9M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Spero Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $10 |
| 2024 | $64 |
| 2023 | $75 |
| 2022 | $49 |
| 2021 | $83 |
| 2020 | $21 |
| 2019 | $32 |
| 2018 | $13 |
| 2017 | $9 |
| 2016 | $7 |
| Spero Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $10 |
| 2024-12-31 | $64 |
| 2023-12-31 | $75 |
| 2022-12-31 | $49 |
| 2021-12-31 | $83 |
| 2020-12-31 | $21 |
| 2019-12-31 | $32 |
| 2018-12-31 | $13 |
| 2017-12-31 | $9 |
| 2016-12-31 | $7 |
Spero Therapeutics Inc. Total Liabilities — FAQ
Spero Therapeutics Inc. (SPRO) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SPRO's total liabilities history?
The chart and table above show Spero Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.